The Adeno-associated Virus Vector-based Gene Therapy Market is making significant strides in treating a diverse range of genetic disorders. AAV's ability to precisely deliver therapeutic genes to target tissues has made it a preferred vector for applications in neurology, hematology, and ophthalmology. For instance, AAV-based therapies have shown remarkable success in treating inherited retinal diseases and certain types of muscular dystrophy, offering long-term benefits and in some cases, a...